CEO sold ~$96K of KRYS shares in the open market

Past results only. Not a forecast.

Record ID

0001298709-26-000009

Filed / recorded

Jun 5, 2026, 10:38 PM UTC

Added to OQRO

Oct 6, 2026, 7:59 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Krystal Biotech, Inc.

Issuer CIK

1711279

Ticker

KRYS

Reporting person

Krish S Krishnan

Relationship

Director, Officer, 10% owner

Officer title

President and CEO

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Jun 4, 2026

Transaction code

S

Shares / units

320

Price per share

$300.75

Acquired / disposed

Disposed (D)

Shares owned after

1,474,933

Ownership form

Direct

Amendment

No

1. The Reporting Person may be deemed to beneficially own shares of the Issuer's common stock directly owned by the Reporting Person's spouse, Suma M. Krishnan. Such shares and transactions by the Reporting Person's spouse are not included in this Form 4, as they are being reported separately on a Form 4 filed by his spouse. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
2. The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025. The Rule 10b5-1 trading plan started on December 4, 2025, and will terminate on December 4, 2026, or earlier in accordance with the terms of the Rule 10b5-1 trading plan, including upon completion of the sale of all of the shares of the Company's common stock subject to the Rule 10b5-1 trading plan.